New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
Statin use not tied to cognitive decline, dementia in seniors
Jun 22, 2021
No association was seen for statin use versus nonuse with dementia, mild cognitive impairment or changes in cognitive function over time.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
American Stroke Association, Feb. 7-9
Feb 20, 2024
The conference featured presentations that emphasized basic, clinical and translational medicine and provided insight into the prevention, management and treatment of stroke.